Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.4B | 5.8B | 5.5B |
Cost of revenue | 3.0B | 3.1B | 2.9B | 2.7B |
Gross profit | 3.0B | 3.3B | 3.0B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 8.8B | 724M | 707M | 657M |
Other operating expenses | -5.9B | 2.1B | 1.9B | 1.8B |
Operating income | 11M | 596M | 347M | 336M |
Non operating interest income | ||||
Income | -14M | 29M | 20M | 24M |
Expense | 20M | 25M | 62M | 115M |
Other income expense | — | — | — | — |
Pretax income | -29M | 601M | 304M | 245M |
Tax provision | -2M | 133M | 93M | 74M |
Net income | -19M | 476M | 206M | 170M |
Basic EPS | — | 2.5 | 1.1 | 1.0 |
Diluted EPS | — | 2.5 | 1.1 | 1.0 |
Basic average shares | — | 178.6M | 179.2M | 178.9M |
Diluted average shares | — | 178.6M | 179.2M | 178.9M |
EBITDA | 292M | 936M | 653M | 633M |
Net income from continuing op. | -29M | 601M | 304M | 245M |
Minority interests | -20M | -33M | -16M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |